Trademark Overview
On Tuesday, September 18, 2007, a trademark application was filed for BYLAREX with the United States Patent and Trademark Office. The USPTO has given the BYLAREX trademark a serial number of 77282666. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, July 28, 2008. This trademark is owned by Amylin Pharmaceuticals, Inc.. The BYLAREX trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, obesity, cardiovascular diseases and disorders, gastrointestinal disorders, immunological disorders, inflammation and inflammatory diseases, neurological disorders, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, urological disorders